Methylnaltrexone
Links shared publicly online about this topic
What Is Relistor (Methylnaltrexone)? Why Do Opioids Cause Constipation?
medicalnewstoday.com — “Relistor (Methylnaltrexone) is a medication for patients who suffer from constipation caused by opioid drugs. Opi” View full resource at medicalnewstoday.com
Most Recently Shared on July 28, 2009 at 10:41 am By:
What Is Relistor (Methylnaltrexone)? Why Do Opioids Cause Constipation?: Relistor (Methylnaltrexone) is a medica.. http://bit.ly/z5haQ
Opioid-Induced Constipation In Critical Care Patients May Be Reduced By Methylnaltrexone
medicalnewstoday.com — “Opioids are a mainstay of care in the critical care unit, but their use frequently causes constipation which can lead to adverse outcomes including delayed feeding and later discharge from the ICU” View full resource at medicalnewstoday.com
Most Recently Shared on March 4, 2012 at 8:05 am By:
MNT Pain News Pain Management and Health News
Opioid-Induced Constipation In Critical Care Patients May Be Reduced By Methylnaltrexone http://t.co/Q5qNrowW #pain
Progenics Pharmaceuticals to advance oral methylnaltrexone for OIC into late stage clinical development
news-medical.net — “Progenics Pharmaceuticals, Inc. today announced that it plans to advance oral methylnaltrexone for the treatment of opioid-induced constipation (OIC) into late stage clinical development and will commence a phase 2b/3 clinical trial of a methylnaltrexone tablet in chronic-pain patients in the second half of 2010. Progenics also announced data from a clinical trial of this methylnaltrexone tablet.” View full resource at news-medical.net
Most Recently Shared on March 15, 2010 at 2:10 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Progenics Pharmaceuticals to advance oral methylnaltrexone for OIC into late stage clinical develop... http://bit.ly/9pGkcu
Progenics Announces Clinical Completion Of Subcutaneous Methylnaltrexone Safety Study In Chronic Non-Malignant Pain Patients
medicalnewstoday.com — “Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bro” View full resource at medicalnewstoday.com
Most Recently Shared on September 23, 2010 at 3:05 pm By:
MNT Gastrointestinal Health News
Progenics Announces Clinical Completion Of Subcutaneous Methylnaltrexone Safety Study In Chronic Non-Malignant Pain Pa... http://mnt.to/3KcC
Methylnaltrexone--"A New Peripheral Opioid Receptor Antagonist--" Clinical Considerations | Gastroenterology
touchgastroenterology.com — “Title: Methylnaltrexone--"A New Peripheral Opioid Receptor Antagonist--" Clinical ConsiderationsAbstract: Abstract Constipation in patients on opioid pain medication contributes significantly to patient discomfort, co-morbidities, and” View full resource at touchgastroenterology.com
Most Recently Shared on March 28, 2011 at 1:05 pm By:
touchGASTRO Gastroenterology and Medical Journal
Methylnaltrexone—A New Peripheral Opioid Receptor Antagonist— Clinical Considerations http://bit.ly/ijjsoX
Methylnaltrexone Has No Significant CNS Activity in Patients with Chronic Nonmalignant Pain and Opioid-Induced Constipation - ONA
oncologynurseadvisor.com — “Subcutaneous methylnaltrexone does not affect pain intensity or analgesic use in patients with chronic nonmalignant pain and opioid-induced constipation, according to a study presented at the American Pain Society's 29th Annual Scientific Meeting.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 8, 2010 at 2:57 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Methylnaltrexone Has No Significant CNS Activity in Patients with Chronic Nonmalignant Pain… http://goo.gl/fb/FoTYY
Methylnaltrexone Demonstrates Long-Term Relief of Opioid-Induced Constipation - MPR
empr.com — “Methylnaltrexone bromide, a selective peripherally acting mu-opioid receptor antagonist, is effective for the long-term treatment of opioid-induced constipation resulting from chronic opioid therapy in chronic non-cancer pain, as demonstrated by study data presented at the American Pain Society’s 30th Annual Scientific Meeting.” View full resource at empr.com
Most Recently Shared on May 21, 2011 at 1:40 pm By:
MPR News: Methylnaltrexone Demonstrates Long-Term Relief of Opioid-Induced Constipation: Methylnaltrexone bromid... http://bit.ly/jeWoqN
Methylnaltrexone Has No Significant CNS Activity in Patients with Chronic Nonmalignant Pain and Opioid-Induced Constipation - MPR
empr.com — “Subcutaneous methylnaltrexone does not affect pain intensity or analgesic use in patients with chronic nonmalignant pain and opioid-induced constipation, according to a study presented at the American Pain Society's 29th Annual Scientific Meeting.” View full resource at empr.com
Most Recently Shared on May 8, 2010 at 2:42 pm By:
APS: Methylnaltrexone Has No Significant CNS Activity in Patients with Chronic Nonmalignant Pain and Opioid-Induce... http://bit.ly/aTHvjF
Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC
news-medical.net — “Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).” View full resource at news-medical.net
Most Recently Shared on September 22, 2010 at 2:05 pm By:
Irritable Bowel Syndrome OW Health
Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC: Progenics ... http://bit.ly/bqhznN
Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC
news-medical.net — “Progenics Pharmaceuticals, Inc. today announced the completion of the treatment phase of a 1,034-patient, one-year, open-label, international, phase 3 safety study of methylnaltrexone bromide subcutaneous injection in chronic, non-malignant pain patients with opioid-induced constipation (OIC).” View full resource at news-medical.net
Most Recently Shared on September 22, 2010 at 10:35 am By:
Progenics completes methylnaltrexone bromide subcutaneous injection phase 3 study in patients with OIC: Progenics ... http://bit.ly/ci10LJ
Methylnaltrexone Demonstrates Long-Term Relief of Opioid-Induced Constipation - ONA
oncologynurseadvisor.com — “Methylnaltrexone bromide, a selective peripherally acting mu-opioid receptor antagonist, is effective for the long-term treatment of opioid-induced constipation resulting from chronic opioid therapy in chronic non-cancer pain, as demonstrated by study data presented at the American Pain Society’s 30th Annual Scientific Meeting.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 21, 2011 at 1:53 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Methylnaltrexone Demonstrates Long-Term Relief of Opioid-Induced Constipation http://goo.gl/fb/Gdu0e
Progenics Announces Results of Methylnaltrexone Phase 3 Safety Study in Chronic, Non-Malignant Pain Patients - Drugs.com MedNews
drugs.com — “Progenics Pharmaceuticals, Inc. (Nasdaq PGNX) today provided analyses of safety and efficacy endpoints from the 1,034-patient, one-year phase 3 safety study of” View full resource at drugs.com
Most Recently Shared on May 20, 2011 at 2:07 pm By:
Drugs and Devices OW OW Health
Progenics Announces Results of Methylnaltrexone Phase 3 Safety Study in Chronic, Non-Malignant Pain Patien... http://bit.ly/l5oybs #drug
Results of Opioid Induced Constipation Drug Trial to be Announced
hcplive.com — “A phase 3 study of a methylnaltrexone bromide subcutaneous injection for OIC completed.” View full resource at hcplive.com
Most Recently Shared on September 23, 2010 at 3:19 pm By:
Results of #Opioid Induced Constipation Drug Trial to be Announced http://hcp.lv/9SrJtu
Medical News: Injection Eases Opioid-Induced Constipation - in Pain Management, Pain Management from MedPage Today
medpagetoday.com — “SAN DIEGO -- Subcutaneous injections of methylnaltrexone (Relistor) can relieve constipation caused by opioid treatment for noncancer pain, researchers said here.” View full resource at medpagetoday.com
Most Recently Shared on May 12, 2009 at 5:39 pm By:
Injection Eases Opioid-Induced Constipation http://twurl.nl/iaxtjz
Medical News: Injection Eases Opioid-Induced Constipation - in Pain Management, Pain Management from MedPage Today
medpagetoday.com — “SAN DIEGO -- Subcutaneous injections of methylnaltrexone (Relistor) can relieve constipation caused by opioid treatment for noncancer pain, researchers said here.” View full resource at medpagetoday.com
Most Recently Shared on May 12, 2009 at 4:34 pm By:
Injection Eases Opioid-Induced Constipation http://medpagetoday.com/14163
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT Health News
Featured health news published by Medical News Today and chosen by the editorial team.
-
MNT Pain News
The latest pain and anesthetics news published daily. Articles from research centers, universities and prestigious journals.
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
Advertisement
